Emerging drugs for high-grade osteosarcoma

Author： Hattinger Claudia Maria Pasello Michela Ferrari Stefano Picci Piero Serra Massimo

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.4, 2010-12, pp. : 615-634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future

By Cavaliere Robert Newton Herbert

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 749-765

Informa Healthcare

Access to resources Recommend Favorite

BPH drugs may increase high-grade prostate cancer risk

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Gastroenteropancreatic high-grade neuroendocrine carcinoma

By Sorbye Halfdan Strosberg Jonathan Baudin Eric Klimstra David S. Yao James C.

Cancer, Vol. 120, Iss. 18, 2014-09 ,pp. : 2814-2823

Blackwell Publishing

Access to resources Recommend Favorite

Antiangiogenic Therapy for High-Grade Gliomas

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 184-194

Bentham Science Publishers

Access to resources Recommend Favorite

Increasing complexity of high-grade B-cell lymphomas

By Armitage James O. Bociek R. Gregory

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1611-1613

Blackwell Publishing

Access to resources Recommend Favorite